成人体外膜肺氧合患者院内转运护理专家共识

2021-08-25 中国临床医学. 2021,28(04)

体外膜肺氧合(extracorporeal membrane oxygenation, ECMO)技术在危重症患者的救治中发挥着重要作用,近年来广泛应用于常规生命支持无效的各种急性呼吸和(或)循环衰竭

中文标题:

成人体外膜肺氧合患者院内转运护理专家共识

发布机构:

发布日期:

2021-08-25

简要介绍:

体外膜肺氧合(extracorporeal membrane oxygenation, ECMO)技术在危重症患者的救治中发挥着重要作用,近年来广泛应用于常规生命支持无效的各种急性呼吸和(或)循环衰竭。危重症患者由于检查、治疗等需求,常面临转运,但目前国内外尚无ECMO患者院内转运的相关指南或共识。本共识结合国内外研究,基于循证和专家论证的方法,从ECMO患者转运的各环节建立共识,以指导临床实践。 
 

相关资料下载:
[AttachmentFileName(sort=1, fileName=成人体外膜肺氧合患者院内转运护理专家共识.pdf)] GetToolGuiderByIdResponse(projectId=1, id=c5a241c002180e6e, title=成人体外膜肺氧合患者院内转运护理专家共识, enTitle=, guiderFrom=中国临床医学. 2021,28(04), authorId=0, author=, summary=体外膜肺氧合(extracorporeal membrane oxygenation, ECMO)技术在危重症患者的救治中发挥着重要作用,近年来广泛应用于常规生命支持无效的各种急性呼吸和(或)循环衰竭, cover=https://img.medsci.cn/202197/1631025114897_2020535.jpg, journalId=0, articlesId=null, associationId=0, associationName=, associationIntro=, copyright=0, guiderPublishedTime=Wed Aug 25 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="row"><span id="ChDivSummary" class="abstract-text" style="color: #666666;">体外膜肺氧合(extracorporeal membrane oxygenation, ECMO)技术在危重症患者的救治中发挥着重要作用,近年来广泛应用于常规生命支持无效的各种急性呼吸和(或)循环衰竭。危重症患者由于检查、治疗等需求,常面临转运,但目前国内外尚无ECMO患者院内转运的相关指南或共识。本共识结合国内外研究,基于循证和专家论证的方法,从ECMO患者转运的各环节建立共识,以指导临床实践。&nbsp;</span></div> <div class="row">&nbsp;</div>, tagList=[TagDto(tagId=8355, tagName=体外膜肺氧合)], categoryList=[CategoryDto(categoryId=38, categoryName=急重症科, tenant=100), CategoryDto(categoryId=79, categoryName=护理, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=8355, guiderKeyword=体外膜肺氧合, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4889, appHits=99, showAppHits=0, pcHits=488, showPcHits=4790, likes=0, shares=14, comments=9, approvalStatus=1, publishedTime=Tue Sep 07 23:10:53 CST 2021, publishedTimeString=2021-08-25, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Tue Sep 07 22:32:52 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Thu Jan 04 02:14:55 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=成人体外膜肺氧合患者院内转运护理专家共识.pdf)])
成人体外膜肺氧合患者院内转运护理专家共识.pdf
下载请点击:
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1182334, encodeId=bcd1118233444, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e396454799, createdName=ms9000001466231458, createdTime=Sat Jan 08 19:41:12 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074518, encodeId=213f10e451838, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=671a5602834, createdName=1792186248@qq.com, createdTime=Sat Nov 27 15:28:24 CST 2021, time=2021-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066581, encodeId=fa63106658168, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a7f61435195, createdName=1027762666, createdTime=Wed Nov 03 13:01:32 CST 2021, time=2021-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061420, encodeId=68c8106142068, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211018/cf8f772ab38148e8ac2cb234229f8f71/4fea1ac6fb8a4a6ca1be5e0817ee1b81.jpg, createdBy=65685639002, createdName=我不是针对谁, createdTime=Mon Oct 18 10:33:25 CST 2021, time=2021-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057612, encodeId=6628105e612c6, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ead5615860, createdName=橡皮檫, createdTime=Mon Oct 04 16:18:57 CST 2021, time=2021-10-04, status=1, ipAttribution=)]
    2022-01-08 ms9000001466231458

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1182334, encodeId=bcd1118233444, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e396454799, createdName=ms9000001466231458, createdTime=Sat Jan 08 19:41:12 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074518, encodeId=213f10e451838, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=671a5602834, createdName=1792186248@qq.com, createdTime=Sat Nov 27 15:28:24 CST 2021, time=2021-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066581, encodeId=fa63106658168, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a7f61435195, createdName=1027762666, createdTime=Wed Nov 03 13:01:32 CST 2021, time=2021-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061420, encodeId=68c8106142068, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211018/cf8f772ab38148e8ac2cb234229f8f71/4fea1ac6fb8a4a6ca1be5e0817ee1b81.jpg, createdBy=65685639002, createdName=我不是针对谁, createdTime=Mon Oct 18 10:33:25 CST 2021, time=2021-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057612, encodeId=6628105e612c6, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ead5615860, createdName=橡皮檫, createdTime=Mon Oct 04 16:18:57 CST 2021, time=2021-10-04, status=1, ipAttribution=)]
    2021-11-27 1792186248@qq.com

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1182334, encodeId=bcd1118233444, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e396454799, createdName=ms9000001466231458, createdTime=Sat Jan 08 19:41:12 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074518, encodeId=213f10e451838, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=671a5602834, createdName=1792186248@qq.com, createdTime=Sat Nov 27 15:28:24 CST 2021, time=2021-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066581, encodeId=fa63106658168, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a7f61435195, createdName=1027762666, createdTime=Wed Nov 03 13:01:32 CST 2021, time=2021-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061420, encodeId=68c8106142068, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211018/cf8f772ab38148e8ac2cb234229f8f71/4fea1ac6fb8a4a6ca1be5e0817ee1b81.jpg, createdBy=65685639002, createdName=我不是针对谁, createdTime=Mon Oct 18 10:33:25 CST 2021, time=2021-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057612, encodeId=6628105e612c6, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ead5615860, createdName=橡皮檫, createdTime=Mon Oct 04 16:18:57 CST 2021, time=2021-10-04, status=1, ipAttribution=)]
    2021-11-03 1027762666

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1182334, encodeId=bcd1118233444, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e396454799, createdName=ms9000001466231458, createdTime=Sat Jan 08 19:41:12 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074518, encodeId=213f10e451838, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=671a5602834, createdName=1792186248@qq.com, createdTime=Sat Nov 27 15:28:24 CST 2021, time=2021-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066581, encodeId=fa63106658168, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a7f61435195, createdName=1027762666, createdTime=Wed Nov 03 13:01:32 CST 2021, time=2021-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061420, encodeId=68c8106142068, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211018/cf8f772ab38148e8ac2cb234229f8f71/4fea1ac6fb8a4a6ca1be5e0817ee1b81.jpg, createdBy=65685639002, createdName=我不是针对谁, createdTime=Mon Oct 18 10:33:25 CST 2021, time=2021-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057612, encodeId=6628105e612c6, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ead5615860, createdName=橡皮檫, createdTime=Mon Oct 04 16:18:57 CST 2021, time=2021-10-04, status=1, ipAttribution=)]
    2021-10-18 我不是针对谁

    值得学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1182334, encodeId=bcd1118233444, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e396454799, createdName=ms9000001466231458, createdTime=Sat Jan 08 19:41:12 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074518, encodeId=213f10e451838, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=671a5602834, createdName=1792186248@qq.com, createdTime=Sat Nov 27 15:28:24 CST 2021, time=2021-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066581, encodeId=fa63106658168, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a7f61435195, createdName=1027762666, createdTime=Wed Nov 03 13:01:32 CST 2021, time=2021-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061420, encodeId=68c8106142068, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211018/cf8f772ab38148e8ac2cb234229f8f71/4fea1ac6fb8a4a6ca1be5e0817ee1b81.jpg, createdBy=65685639002, createdName=我不是针对谁, createdTime=Mon Oct 18 10:33:25 CST 2021, time=2021-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057612, encodeId=6628105e612c6, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ead5615860, createdName=橡皮檫, createdTime=Mon Oct 04 16:18:57 CST 2021, time=2021-10-04, status=1, ipAttribution=)]
    2021-10-04 橡皮檫

    0

拓展阅读

肺移植围手术期体外膜肺氧合应用指南(2019版)

中华医学会器官移植学分会 · 2019-07-25

体外膜肺氧合在成人新型冠状病毒感染合并心血管急危重症患者中的使用专家共识

中国医师协会心血管内科医师分会(CCCP,Chinese College of Cardiovascular Physicians) · 2020-03-17

体外膜肺氧合(ECMO)技术临床应用管理规范

中华人民共和国国家卫生健康委员会 · 2020-12-09

成人体外膜肺氧合患者院际转运专家共识

中国医药教育协会 · 2020-02-20

2021 KSTCVS建议:体外膜肺氧合治疗COVID-19

国外胸外科相关专家组(统称) · 2021-02-05